Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
43 pending office actions • 29 art units • 43 examiners • 0 of 43 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days
New York University is managing 42 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 29 distinct art units, reflecting a wide-ranging research and development focus. Such a high number of art units suggests that the university's patentable output spans many specialized fields within biotechnology, necessitating a sophisticated approach to managing various examination timelines.
The portfolio involves 42 distinct examiners. This matches the total number of pending office actions, indicating that no single examiner currently holds a concentrated portion of the university's active prosecution workload. TOKARCZYK, CHRISTOPHER B is identified as the busiest examiner with 1 pending office action. This distribution means that the prosecution team must adapt to many different individual perspectives, requiring the university to track a vast array of examiner-specific data to optimize their response strategies across the board. Practitioners should be prepared for a highly decentralized prosecution environment where individual examiner tendencies significantly influence the outcome of each application.
Based on the USPTO statutory response window for each pending office action. 16 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 16 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 9 (21%) |
| §103 only | 8 (19%) |
| §102 only | 3 (7%) |
| §112 only | 3 (7%) |
| Double-patenting only | 1 (2%) |
| Double-patenting + other | 2 (5%) |
| Multi-statute (no §101) | 17 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TOKARCZYK, CHRISTOPHER B | 1 | 43.7% | +23.7% |
| NGUYEN, HAIDUNG D | 1 | 64.9% | +28.4% |
| NEWTON, CHAD A | 1 | 37.6% | +23.2% |
| MELHUS, BENJAMIN S | 1 | 60.4% | +44.1% |
| FULLER, RODNEY EVAN | 1 | 83.9% | +7.9% |
| FANG, PAKEE | 1 | 67.7% | +36.9% |
| SANGHERA, JAS A | 1 | 94.5% | +5.0% |
| MCANANY, JOHN D | 1 | 67.2% | +43.7% |
| HUANG, MICKEY NMN | 1 | 59.6% | +49.2% |
| CORNET, JEAN P | 1 | 42.1% | +47.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18923344 | SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR DETERMINING ROTATIONAL INVARIANTS OF CUMULANT EXPANSION FROM ONE OR MORE ACQUISITIONS WHICH CAN BE MINIMAL | FULLER, RODNEY EVAN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000772 | MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE | SALVOZA, M FRANCO G | 71d overdue |
| 19067406 | Doped Organic Semiconductors and Methods of Making the Same | NGUYEN, HAIDUNG D | 45d overdue |
| 18257504 | CHEMICALLY MODIFIED CRISPR-CAS13 GUIDE RNAS | KONOPKA, CATHERINE ANNE | 38d overdue |
| 18251384 | ENHANCEMENT OF PREDICTABLE AND TEMPLATE-FREE GENE EDITING BY THE ASSOCIATION OF CAS WITH DNA POLYMERASE | TATGE, LEXUS MARC | 37d overdue |
| 18297160 | NASAL MOLDING DEVICE | JAMIALAHMADI, MAJID | 26d overdue |
| 18575905 | SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FACILITATING DEPLOYMENT OF ANTIDEPRESSANTS AND OTHER PRESCRIPTION DRUGS | HUYNH, EMILY | 8d |
| 17637427 | TARGETING SLC38A2 IN PANCREATIC CANCER | ANGELL, JON E | 9d |
| 17626598 | METHODS AND COMPOSITIONS FOR SCALABLE POOLED RNA SCREENS WITH SINGLE CELL CHROMATIN ACCESSIBILITY PROFILING | YOUNG, BRIAN ELLIS | 30d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19067406 | Doped Organic Semiconductors and Methods of Making the Same | NGUYEN, HAIDUNG D | 45d overdue |
| 19292081 | SYSTEMS, APPARATUS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING HEALTH SYSTEM SCALE LANGUAGE MODELS WHICH CAN INCLUDE CLINICAL PREDICTION ENGINES | TOKARCZYK, CHRISTOPHER B | — |
| 18940457 | SYSTEM AND METHOD FOR ASSESSING INTRACRANIAL ANEURYSMS | NEWTON, CHAD A | — |
| 18937417 | Methods And Kits For Assessing Neurological And Ophthalmic Function And Localizing Neurological Lesions | MELHUS, BENJAMIN S | — |
| 18851344 | METHODS AND APPARATUS FOR MOBILITY PROCEDURES FOR HIGHLY DIRECTIONAL SYSTEMS | FANG, PAKEE | — |
| 18826792 | COMPOSITIONS AND METHODS FOR ENHANCING KRAS INHIBITOR OR SHP2 INHIBITOR EFFICACY | MCANANY, JOHN D | — |
| 18815038 | Discrete Microenvironment Chamber | HUANG, MICKEY NMN | — |
| 18835261 | USE OF RETINOIDS FOR TREATMENT OF ATRIAL FIBRILLATION | CORNET, JEAN P | — |
| Art Unit | Apps |
|---|---|
| 3791 | 3 |
| 1658 | 2 |
| 1654 | 2 |
| 1637 | 2 |
| 1761 | 1 |
| 3681 | 1 |
| 2852 | 1 |
| 1758 | 1 |
| 2872 | 1 |
| 3797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19292081 | SYSTEMS, APPARATUS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING HEALTH SYSTEM SCALE LANGUAGE MODELS WHICH CAN INCLUDE CLINICAL PREDICTION ENGINES | TOKARCZYK, CHRISTOPHER B | — | §101§102§103 | Non-Final OA | — | Pending | Aug 06, 2025 |
| 19067406 | Doped Organic Semiconductors and Methods of Making the Same | NGUYEN, HAIDUNG D | 1761 | §102§103§112 | Final Rejection | 45d overdue | Pending | Feb 28, 2025 |
| 18940457 | SYSTEM AND METHOD FOR ASSESSING INTRACRANIAL ANEURYSMS | NEWTON, CHAD A | 3681 | §101§103 | Final Rejection | — | Pending | Nov 07, 2024 |
| 18937417 | Methods And Kits For Assessing Neurological And Ophthalmic Function And Localizing Neurological Lesions | MELHUS, BENJAMIN S | — | §103Other | Non-Final OA | — | Pending | Nov 05, 2024 |
| 18923344 | SYSTEM, METHOD AND COMPUTER-ACCESSIBLE MEDIUM FOR DETERMINING ROTATIONAL INVARIANTS OF CUMULANT EXPANSION FROM ONE OR MORE ACQUISITIONS WHICH CAN BE MINIMAL | FULLER, RODNEY EVAN | — | §102Other | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18851344 | METHODS AND APPARATUS FOR MOBILITY PROCEDURES FOR HIGHLY DIRECTIONAL SYSTEMS | FANG, PAKEE | — | §102§103 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18848241 | DEVICES AND METHODS FOR RAPID BIOSENSING | SANGHERA, JAS A | 2852 | §102§103§112 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18826792 | COMPOSITIONS AND METHODS FOR ENHANCING KRAS INHIBITOR OR SHP2 INHIBITOR EFFICACY | MCANANY, JOHN D | — | §102§103 | Non-Final OA | — | Pending | Sep 06, 2024 |
| 18815038 | Discrete Microenvironment Chamber | HUANG, MICKEY NMN | 1758 | §102§103 | Final Rejection | — | Pending | Aug 26, 2024 |
| 18835261 | USE OF RETINOIDS FOR TREATMENT OF ATRIAL FIBRILLATION | CORNET, JEAN P | — | §112 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18765178 | PATIENT-ACCESSIBLE CALIBRATION OF VIDEO EYETRACKING APPARATUS | SHIN, SOO JUNG | 2872 | §102§112 | Non-Final OA | — | Pending | Jul 05, 2024 |
| 18646234 | SYSTEMS, METHODS, AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING HUMAN-MODEL ALIGNMENT USING METADATA AND ARTIFACTS, PATIENT INFORMATION, OR SYNTHETIC DATA | GURMU, MULUEMEBET | — | §103 | Non-Final OA | — | Pending | Apr 25, 2024 |
| 18690480 | SYSTEM AND METHOD FOR STEREOSCOPIC IMAGE GENERATION | BRUTUS, JOEL F | 3797 | §103 | Final Rejection | 8d overdue | Pending | Mar 08, 2024 |
| 18434053 | SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FOR PROVIDING A LANGUAGE MODEL POPULATION SIMULATOR | ALBERTALLI, BRIAN LOUIS | 2656 | §102 | Non-Final OA | 55d | Pending | Feb 06, 2024 |
| 18294021 | NORA INHIBITORS AND METHODS OF USE | COFFA, SERGIO | — | §102 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18580093 | AUF1 COMBINATION THERAPIES FOR TREATMENT OF MUSCLE DEGENERATIVE DISEASE | PRONZATI, GINA | 1631 | §103§112 | Non-Final OA | — | Pending | Jan 17, 2024 |
| 18575905 | SYSTEMS, METHODS AND COMPUTER-ACCESSIBLE MEDIUM FACILITATING DEPLOYMENT OF ANTIDEPRESSANTS AND OTHER PRESCRIPTION DRUGS | HUYNH, EMILY | 3683 | §101§112 | Non-Final OA | 8d | Pending | Jan 02, 2024 |
| 18508879 | Smart Wearable IOT Device for Health Tracking, Contact Tracing and Prediction of Health Deterioration | HUSSAINI, ATTIYA SAYYADA | 3792 | §102§103§112 | Non-Final OA | — | Pending | Nov 14, 2023 |
| 18487767 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING AUTOIMMUNE INDUCED CARDIAC LONG QT SYNDROME | WEIDNER, ADAM M | 1675 | DP | Final Rejection | 26d overdue | Pending | Oct 16, 2023 |
| 18370695 | MULTIVALENT PEPTOID OLIGOMERS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING SAME | FISCHER, JOSEPH | 1658 | §112Other | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18467202 | SYSTEM AND METHOD FOR AUTONOMOUS CHARGING | OMAR, AHMED H | — | §102§103 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18280186 | APPLICATION OF APOPTOSIS INHIBITOR 5 (API5) FOR EPITHELIAL RESTITUTION | HA, JULIE | 1654 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18460519 | FLUORINATED FIBERS FOR MULTIMODAL 1H AND 19F MRI, ULTRASOUND, FLUORESCENCE DETECTION AND CONFORMATIONAL AND TEMPERATURE DETECTION BY 19F MRS | VARADARAJ, ARCHANA | 1658 | §102§103§112DP | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18264314 | METHODS AND BIOMARKERS IN CANCER | MYERS, CARLA J | 1682 | §101§103§112Other | Non-Final OA | — | Pending | Aug 04, 2023 |
| 18259637 | CROSSLINKED HELIX DIMER MIMICS OF SOS AND METHODS OF USING SAME | GARYU, LIANKO G | 1654 | §101§102§103§112DPOther | Non-Final OA | — | Pending | Jun 28, 2023 |
| 18257609 | WEARABLE INERTIAL SENSOR SYSTEM AND METHODS | YOON, CHANEL J | 3791 | §101§103§112 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18257504 | CHEMICALLY MODIFIED CRISPR-CAS13 GUIDE RNAS | KONOPKA, CATHERINE ANNE | 1635 | §102§103§112Other | Final Rejection | 38d overdue | Pending | Jun 14, 2023 |
| 18041627 | Methods and Compositions for Inhibiting Viral Infection | OH, TAYLOR V | 1625 | §102§103§112 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18252285 | NPC1 MONOBODIES AND MONOBODY CONJUGATES THEREOF | PETERS, ALEC JON | 1641 | §103§112 | Non-Final OA | — | Pending | May 09, 2023 |
| 18251384 | ENHANCEMENT OF PREDICTABLE AND TEMPLATE-FREE GENE EDITING BY THE ASSOCIATION OF CAS WITH DNA POLYMERASE | TATGE, LEXUS MARC | 1637 | §101§102§103§112 | Non-Final OA | 37d overdue | Pending | May 01, 2023 |
| 18303421 | IL-17 RECEPTOR MODULATOR SCREENING SYSTEM | ABBAS, SYED JARAR | 1656 | §103§112 | Non-Final OA | — | Pending | Apr 19, 2023 |
| 18297160 | NASAL MOLDING DEVICE | JAMIALAHMADI, MAJID | 3771 | §103§112 | Non-Final OA | 26d overdue | Pending | Apr 07, 2023 |
| 18101105 | DIGITAL WITNESS SYSTEMS AND METHODS FOR AUTHENTICATING AND CONFIRMING THE INTEGRITY OF A DIGITAL ARTIFACT | GELAGAY, SHEWAYE | 2400 | §103 | Final Rejection | 112d overdue | Pending | Jan 24, 2023 |
| 18000772 | MODIFIED ALPHAVIRUS FOR USE AS COVID-19 VACCINE | SALVOZA, M FRANCO G | 1672 | §103§112 | Non-Final OA | 71d overdue | Pending | Dec 05, 2022 |
| 18000212 | HIGH DENSITY EEG SYSTEM FOR PRECISION PSYCHIATRY | EPPERT, LUCY CLARE | 3791 | §103 | Non-Final OA | — | Pending | Nov 29, 2022 |
| 17789047 | THE COMBINATION OF CYCLIN DEPENDENT KINASE 7 INHIBITOR AND IMMUNOTHERAPY FOR TREATMENT OF CANCER | SCHMIDT, IZABELA MARIA | 1621 | §103Other | Final Rejection | 30d | Pending | Jun 24, 2022 |
| 17642471 | HIGH-GAIN AMORPHOUS SELENIUM PHOTOMULTIPLIER | YECHURI, SITARAMARAO S | 2893 | §112 | Final Rejection | 22d | Pending | Mar 11, 2022 |
| 17637427 | TARGETING SLC38A2 IN PANCREATIC CANCER | ANGELL, JON E | 1637 | §102§103 | Non-Final OA | 9d | Pending | Feb 22, 2022 |
| 17626598 | METHODS AND COMPOSITIONS FOR SCALABLE POOLED RNA SCREENS WITH SINGLE CELL CHROMATIN ACCESSIBILITY PROFILING | YOUNG, BRIAN ELLIS | 1684 | §103§112 | Final Rejection | 30d | Pending | Jan 12, 2022 |
| 17445915 | SYSTEM AND METHOD FOR CONCUSSIVE IMPACT MONITORING | ORTEGA, MARTIN NATHAN | 3791 | §103 | Non-Final OA | — | Pending | Aug 25, 2021 |
| 17371613 | GRAPHITIC CARBON NITRIDE MATERIALS AND METHODS OF MAKING AND USE THEREOF | ALEJANDRO, RAYMOND | 1752 | §103 | Final Rejection | 28d | Pending | Jul 09, 2021 |
| 17152463 | ADENO-ASSOCIATED VIRAL VECTOR, COMPOSITIONS, METHODS OF PROMOTING MUSCLE REGENERATION, AND TREATMENT METHODS | NICOL, ALEXANDER W | 1634 | §103§112DP | Non-Final OA | 72d overdue | Pending | Jan 19, 2021 |
| 16960530 | SYSTEM AND METHOD FOR BLOOD GLUCOSE MONITORING USING MAGNETIC RESONANCE SPECTROSCOPY | ROBINSON, NICHOLAS A | 3798 | §101§102§103§112 | Non-Final OA | — | Pending | Jul 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial